4baseCare is a precision oncology healthcare startup headquartered in Bengaluru, India. Co-founded by Hitesh Goswami and Kshitij Rishi, 4baseCare is committed to making precision oncology the standard of care across Asia by improving the adoption of genomic testing in oncology. The company is pioneering the development of the first South Asian population-specific cancer gene panel to analyze multiple genes for cancer-associated mutations, enabling better-personalized cancer treatment and improved patient outcomes.
4baseCare develops affordable, accessible precision oncology solutions by combining advanced genomics with next-generation digital health technologies. It is building a unified digital health platform that generates, curates, and securely stores comprehensive genetic and clinical data of cancer patients. The company actively collaborates with a robust network of research institutions, technology partners, clinicians, and community organizations to accelerate cancer research and improve clinical outcomes.
A significant milestone was achieved in March 2025 when 4baseCare’s genomics laboratory in Dubai Science Park obtained CAP (College of American Pathologists) accreditation, ensuring global standards of quality and precision in genomic profiling for cancer patients in the UAE and Middle East. This advancement eliminates the need for patients to seek genomic testing outside the region, further democratizing access to precision oncology.
In 2024, 4baseCare raised $6 million in a Series A funding round led by Yali Capital, with participation from prominent investors including Infosys Innovation Fund. This funding supports expanding product offerings, scaling operations, and establishing new genomics laboratories in the Philippines, Nepal, and Dubai, targeting growth across Asia and the Middle East.
Mount Judi Ventures was the lead investor in their Pre-Series A round of USD 2M in February 2021 along with other US and Indian based VCs and angels.
For further details, please visit https://4basecare.com/